Lv11
40 积分 2023-10-16 加入
Hemin enhances radiosensitivity of lung cancer cells through ferroptosis
4小时前
待确认
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
4天前
已完结
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors
5天前
已完结
Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma
5天前
已完结
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
10天前
已完结
mRECIST for HCC: Performance and novel refinements
11天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
13天前
已完结
Tumour hypoxia in driving genomic instability and tumour evolution
14天前
已完结
Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria
1个月前
已完结
Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy
1个月前
已完结
皖公网安备34019202002308
